Novavax, COVID-19
Which COVID vaccine is better of the Pfizer, Modern and Novavax options? Here's how they compare with safety and efficacy and ...
While the new mRNA vaccines from Moderna and Pfizer-BioNTech have dominated the COVID-19 vaccine story, there is another type ...
In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...
On Thursday, Novavax Inc (NVAX) stock saw a decline, ending the day at $14.42 which represents a decrease of $-0.26 or -1.77% from the prior close of $14.68. The stock opened at $14.07 and touched a ...
Shares of Novavax Inc. NVAX shed 5.62% to $13.61 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.22% to ...
Novavax's financial position improved significantly with a $570 million cash infusion from Sanofi. Find out why I remain ...
In a report released today, Roger Song from Jefferies maintained a Buy rating on Novavax (NVAX – Research Report), with a price target of ...
It is still a thing." Health Canada also approved the protein-based Novavax vaccine (Nuvaxovid) last week. It's designed to target JN.1, which is the dominant lineage in Canada at the moment.
Novavax (NASDAQ:NVAX) shares climbed 15% Wednesday after Jefferies released a bullish note on the company’s prospects after ...